Stay updated on Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The revision label updated from v3.4.1 to v3.4.2. No study details or results are affected.
    Difference
    0.0%
    Check dated 2026-02-13T12:39:12.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 and removed Revision: v3.4.0.
    Difference
    0.0%
    Check dated 2026-02-05T23:53:15.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4; there are no substantive changes to the study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T05:15:01.000Z thumbnail image
  5. Check
    64 days ago
    Change Detected
    Summary
    The page’s Locations section was updated to add numerous locations across the US, Australia, Canada, Europe and Asia, and several previously listed sites were removed.
    Difference
    1%
    Check dated 2025-12-23T22:22:47.000Z thumbnail image
  6. Check
    93 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and may not be about the study. Revision: v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-25T10:47:47.000Z thumbnail image
  7. Check
    100 days ago
    Change Detected
    Summary
    The funding-lapse operating-status notice on the page was removed, eliminating the informational banner about potential processing delays. This change does not affect the study details or accessibility of the trial information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T06:57:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.